March 14 A Minnesota medical device company with operations in Westboro has agreed to be acquired by a Canadian business for about $239 million. No information was immediately disclosed about the Westboro facility at 135 Flanders Road. Cogentix moved its Natick operations to the Westboro office in 2015, according to regulatory filings.
Sarasota, FL 03/14/2018 Global Clinical Trial Imaging Market: Overview. The use of the imaging systems in the non-clinical and clinical trials is been carried out since long. The clinical imaging is majorly used to obtain human physiology or anatomy information's which are undeniable as well as interpretable.
Sarasota, FL 03/14/2018 Global Medical Imaging Market: Overview. Medical imaging is a process of creating visual representations of internal parts of the body for medical intervention along with clinical analysis. It assists in diagnosing and treating the diseases properly.
Electrosurgery refers to the use of high-frequency electric current during surgical procedures for the purpose of coagulation, cutting, and fulguration of tissues. Electrosurgery devices enable the surgeons to make precise cuts with controlled blood ...
Surgical power tools are medical instruments, which are activated by an additional power source. Surgical power tools aid in performing specific actions in a surgical procedure such as modifying biological tissue or gaining access for viewing an orga...
"Today we will be examining the FDA's Animal Drug User Fee program and the Animal Generic Drug User Fee program. These critical user fee agreements have helped to accelerate the development of animal drugs, reduce application review times at FDA, and create a more predictable and streamlined process for getting animal drugs to market to help improv
Strides Shasun has obtained approval from the US health regulator. US Food and Drug Administration for its generic Efavirenz tablet. The approval was granted to Strides Pharma Global Pte a wholly owned subsidiary of Strides Shasun for Efavirenz tablets 600 milligram.
WAREHAM, Mass., March 14, 2018/ PRNewswire-USNewswire/ The 150 registered nurses who work at Tobey Hospital, and who are unionized with the Massachusetts Nurses Association, received welcome news last week in the form of a ratified contract and a National Labor Relations Board settlement that put closure to a contract fight that has been ongoing
"Polar Magnetic Resonance Imaging and Applications Thereof in Cardiac Magnetic Resonance Imaging" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Computer Weekly News A patent application by the inventors Nasiraei Moghaddam, Abbas; Golshani, Shokoufeh, filed on October 30, 2017, was made available online on March 1
Mike Topper, President of the American Veterinary Medical Association. A drug that is approved by the FDA has been shown through rigorous studies to be safe and effective for its labeled indication. Unfortunately, there simply are not enough FDA approved drugs for use in animals.
By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors VON SEGESSER, Ludwig K.; DELALOYE, Stephane, filed on June 23, 2017, was made available online on March 1, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Symetis SA. The
"Synthetic Miniature Protein Scaffolds, Pharmaceutical Compositions and Methods of Using Same" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Kirshenbaum, Kent; Craven, Timothy, filed on August 16, 2017, was made available online on March 1, 2018, according to new
Houston, TX 03/14/2018 3 D printing helps make what was once expensive and inaccessible much more cost-effective. Can this be more apt and necessary anywhere else than in the field of medicine? Top Key Vendors: Aprecia Pharmaceuticals, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC, 3 D Printer Drug Machine, and FabRx Ltd..
Albany, NY 03/14/2018 The global market for 3 D printing medical device market is witnessing the rise of a number of small- and medium-scale companies, rendering the vendor landscape increasingly competitive, observes Transparency Market Research in a recent report. Recently, Philips signed an agreement with the 3 D printing medical devices c
Let's just call the outcome of the special Republican primary for a vacant state Senate seat in the Russellville area a victory for Obamacare. Asa Hutchinson and just about every special interest lobbyist you can imagine, beat Robert Bailey, 4,264-3,451. She'll face Democrat Teresa Gallegos, one of the new breed of resisters, in May for the right t
ABBOTT PARK- Abbott today announced the U.S. Food and Drug Administration approved the Masters HP 15 mm rotatable mechanical heart valve, the world's smallest mechanical heart valve, that will allow doctors to treat babies and toddlers in need of a mitral or aortic valve replacement. 'In my practice, I want to be able to provide a treatment option
AbbVie, a global research and development-based biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc., announced that the Phase 3 ELARIS UF-II study of elagolix met its primary endpoint.
The pharma giant$ ABBV has rolled up its second and final positive Phase III for elagolix, one of its top blockbuster hopefuls that is now being pointed to the FDA in search of a near-term approval for treating uterine fibroids. AbbVie is already looking at a Q2 decision from the FDA on endometriosis. AbbVie isnt the only company in the clinic with
Acasti Pharma Inc. today announced that the first patient has been randomized in the company's TRILOGY Phase 3 program evaluating lead drug candidate CaPre for the treatment of severe hypertriglyceridemia, a condition of elevated triglycerides in the bloodstream that increases the risk of coronary artery disease and pancreatitis.
Actinium Pharmaceuticals, Inc. announced today that the Medical College of Wisconsin received clearance from the U.S. Food and Drug Administration for the previously announced Investigational New Drug application for the Phase 1 trial of Actimab-A in combination with CLAG-M for relapsed or refractory Acute Myeloid Leukemia patients.
Actinium Pharmaceuticals, Inc. announced today that Dr. Dr. Rowlands will be responsible for developing clinical regulatory strategies for Actinium s antibody radio-conjugate based drug candidates. In addition, Dr. Rowlands will be responsible for supporting the development of a regulatory pathway for Actinium s planned Actimab-MDS clinical
ADAMAS PHARMACEUTICALS,INC. (NASDAQ:ADMS) Files An 8-K Other EventsItem 8.01Other Events. On March 13, 2018, the U.S. Food and Drug Administration's (FDA) New Paragraph IV Certifications list was updated to reflect that an abbreviated new drug application (ANDA) seeking authorization from the FDA to manufacture, use, or sell a generic
Pune, India 03/13/2018 Advanced X-Ray Visualization Systems Market analysis report speaks about the manufacturing process. Advanced X-Ray Visualization Systems market report also analyses the market growth, Market trends, market overview& market forecast to 2022. Key vendors profiled in the report: Philips Healthcare, GE Healthcare, Fujifilm,
Advaxis, Inc., a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announces financial results for the three months ended January 31, 2018 and provides a business update. The clinical hold pertains to a recent submission of a safety report to the FDA regarding a Grade 5 Ser
Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced that Richard Rubino, Chief Financial Officer, will present in a fireside chat discussion at th